Literature DB >> 15667213

Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.

Shu-Hsien Sheu1, Taner Kaya, David J Waxman, Sandor Vajda.   

Abstract

Solvent mapping moves molecular probes, small organic molecules containing various functional groups, around the protein surface, finds favorable positions, clusters the conformations, and ranks the clusters based on the average free energy. Using at least six different solvents as probes, the probes cluster in major pockets of the functional site, providing detailed and reliable information on the amino acid residues that are important for ligand binding. Solvent mapping was applied to 12 structures of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand-binding domain (LBD), including 2 structures without a ligand, 2 structures with a partial agonist, and 8 structures with a PPAR agonist bound. The analysis revealed 10 binding "hot spots", 4 in the ligand-binding pocket, 2 in the coactivator-binding region, 1 in the dimerization domain, 2 around the ligand entrance site, and 1 minor site without a known function. Mapping is a major source of information on the role and cooperativity of these sites. It shows that large portions of the ligand-binding site are already formed in the PPARgamma apostructure, but an important pocket near the AF-2 transactivation domain becomes accessible only in structures that are cocrystallized with strong agonists. Conformational changes were seen in several other sites, including one involved in the stabilization of the LBD and two others at the region of the coactivator binding. The number of probe clusters retained by these sites depends on the properties of the bound agonist, providing information on the origin of correlations between ligand and coactivator binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15667213     DOI: 10.1021/bi048032c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

Review 1.  Evolutionary origins of the estrogen signaling system: insights from amphioxus.

Authors:  G V Callard; A M Tarrant; A Novillo; P Yacci; L Ciaccia; S Vajda; G-Y Chuang; D Kozakov; S R Greytak; S Sawyer; C Hoover; K A Cotter
Journal:  J Steroid Biochem Mol Biol       Date:  2011-04-14       Impact factor: 4.292

2.  Domain motion and interdomain hot spots in a multidomain enzyme.

Authors:  Gwo-Yu Chuang; Ritcha Mehra-Chaudhary; Chi-Ho Ngan; Brandon S Zerbe; Dima Kozakov; Sandor Vajda; Lesa J Beamer
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

3.  Optimal clustering for detecting near-native conformations in protein docking.

Authors:  Dima Kozakov; Karl H Clodfelter; Sandor Vajda; Carlos J Camacho
Journal:  Biophys J       Date:  2005-05-20       Impact factor: 4.033

4.  Can we use docking and scoring for hit-to-lead optimization?

Authors:  Istvan J Enyedy; William J Egan
Journal:  J Comput Aided Mol Des       Date:  2008-01-09       Impact factor: 3.686

5.  Ligand-escape pathways from the ligand-binding domain of PPARgamma receptor as probed by molecular dynamics simulations.

Authors:  D Genest; N Garnier; A Arrault; C Marot; L Morin-Allory; M Genest
Journal:  Eur Biophys J       Date:  2007-10-11       Impact factor: 1.733

6.  Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism.

Authors:  Travis S Hughes; Michael J Chalmers; Scott Novick; Dana S Kuruvilla; Mi Ra Chang; Theodore M Kamenecka; Mark Rance; Bruce A Johnson; Thomas P Burris; Patrick R Griffin; Douglas J Kojetin
Journal:  Structure       Date:  2012-01-11       Impact factor: 5.006

7.  13-Oxo-9(Z),11(E),15(Z)-octadecatrienoic acid activates peroxisome proliferator-activated receptor γ in adipocytes.

Authors:  Haruya Takahashi; Hideyuki Hara; Tsuyoshi Goto; Kosuke Kamakari; Nomura Wataru; Shinsuke Mohri; Nobuyuki Takahashi; Hideyuki Suzuki; Daisuke Shibata; Teruo Kawada
Journal:  Lipids       Date:  2014-11-27       Impact factor: 1.880

8.  Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article.

Authors:  Mohammed T Qaoud; Ihab Almasri; Tijen Önkol
Journal:  Turk J Pharm Sci       Date:  2022-06-27

9.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

10.  The structural basis of pregnane X receptor binding promiscuity.

Authors:  Chi-Ho Ngan; Dmitri Beglov; Aleksandra N Rudnitskaya; Dima Kozakov; David J Waxman; Sandor Vajda
Journal:  Biochemistry       Date:  2009-12-08       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.